Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage-Antibiotic Combination Therapy for Multidrug-Resistant Infections
ChiCTR2600116642Phase 2Not yet recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Jan 2026
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bacteriophages in bacterial disease (2 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoint: Clinical response rate. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
bacteriophages
03
Conditions
bacterial disease
Beyond the preview
Go deeper on ChiCTR2600116642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116642.